Rysomep-LSR

Description

Rysomep-LSR is an ANVIS combination capsule product. The original carton names enteric-coated esomeprazole and sustained-release levosulpiride and states a pack of ten capsules. This entry preserves the formulation details that distinguish it from other similarly named digestive medicines.

Rysomep-LSR product specification

• Labelled ingredients: Esomeprazole and levosulpiride
• Strength information: Confirm both ingredient amounts on the complete supplied label
• Dosage form: Capsules with enteric-coated esomeprazole and sustained-release levosulpiride
• Pack presentation: 1 × 10 capsules
• Brand: ANVIS

Ingredient background

Esomeprazole reduces stomach acid. Levosulpiride is a prokinetic medicine that affects digestive movement. However, a clinician must assess the need for this specific combination. Its release characteristics also matter. Do not replace it with another digestive product merely because the brand name or capsule count looks similar.

Important precautions

Discuss heart rhythm problems, seizures, pregnancy, breastfeeding and other medicines before treatment. Levosulpiride has important precautions involving gut bleeding or obstruction and may cause movement or hormonal side effects. Also ask about new tremor, stiffness or unusual symptoms during use. Therefore, follow the supplied leaflet and attend the review arranged by the prescriber.

Identifying the original presentation

Before use, match the full name on the outer carton and inner packaging. Also compare the quantitative composition with the prescription or professional recommendation. Similar names and pack colours do not establish that two products have the same formula. Ask a pharmacist to explain any difference before making a substitution.

Inspect the seals, batch details and expiry date of the actual supplied pack. Keep the original packaging and leaflet available for reference. In addition, follow its storage instructions and keep the product out of children’s reach. The pack size describes the contents; it does not define a daily regimen or treatment duration.

Documentation and enquiries

For general ingredient background, read the AEMPS levosulpiride reference. However, this reference does not establish the complete specification or approval of this ANVIS product. For further documentation or availability, contact ANVIS with the exact name and presentation. Alternatively, browse the ANVIS product catalogue to compare other products.